Ulcerative Colitis (UC) , others
Conditions
Interventions
This study is designed as a retrospective study. It does not include randomization, a control group, or an intervention. After patients are identified for the study, their prognosis will be determined
effect size will be determined based on the study results). Since the patients will be included in the study as an observational study, no procedures will be performed. The prognostic status of patien
Sponsors
Akdeniz University
Akdeniz University
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients diagnosed with active Ulcerative Colitis admitted to the hospital between June 2020 and December 2024; availability of complete medical history, laboratory parameters, and colonoscopic findings in the patient files; individuals considered as healthy controls for comparison purposes
Exclusion criteria
Exclusion criteria: Patients diagnosed with Ulcerative Colitis admitted outside the specified study period (June 2020 to December 2024); patients with incomplete medical history or missing data on disease activity, colonoscopic findings, or laboratory parameters; patients with concurrent diagnoses of other inflammatory bowel diseases (e.g., Crohn's Disease); patients with a history of colectomy; healthy controls with any active inflammatory disease or chronic systemic condition
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the assessment of the diagnostic and prognostic value of the CALLY index in relation to active Ulcerative Colitis (UC) disease activation as measured by comparison of CALLY index values between patients with active Ulcerative Colitis and Healthy Controls and comparison of CALLY index values with established clinical features and disease activity levels | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are the analysis of the correlation between the CALLY index and specific colonoscopic findings in patients with active Ulcerative Colitis; and the correlation between the CALLY index and various laboratory parameters including complete blood count (CBC) values erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels in active Ulcerative Colitis patients | — |
Countries
Turkey
Contacts
Public ContactBülent Yildirim
Akdeniz University
Outcome results
None listed